Potential disease trigger as a therapeutic option: infliximab for paradoxical reaction in tuberculosis of the central nervous system.

Briner, Myriam; Oberholzer, Michael; Wagner, Franca; Chan, Andrew

Briner, Myriam; Oberholzer, Michael; Wagner, Franca; Chan, Andrew.

Afiliación

Briner M; Department of Neurology, Inselspital, Bern University Hospital, University of Bern, 3010 Bern, Switzerland myriam.briner@insel.ch.
Oberholzer M; Department of Neurology, Inselspital, Bern University Hospital, University of Bern, 3010 Bern, Switzerland.
Wagner F; Diagnostic and Interventional Neuroradiology, Inselspital University Hospital Bern, 3010 Bern, Switzerland.
Chan A; Department of Neurology, Inselspital, Bern University Hospital, University of Bern, 3010 Bern, Switzerland.

BMJ Case Rep ; 14(8)2021 Aug 02.

Article en En | MEDLINE | ID: mdl-34340991

Asunto(s)

Síndrome Inflamatorio de Reconstitución Inmune; Tuberculosis Miliar; Corticoesteroides/uso terapéutico; Adulto; Antituberculosos/uso terapéutico; Sistema Nervioso Central; Humanos; Síndrome Inflamatorio de Reconstitución Inmune/tratamiento farmacológico; Infliximab/efectos adversos; Tuberculosis Miliar/tratamiento farmacológico

Palabras clave

TB and other respiratory infections; immunological products and vaccines; immunology; infection (neurology); meningitis

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Tuberculosis Miliar / Síndrome Inflamatorio de Reconstitución Inmune Límite: Adult / Humans Idioma: En Revista: BMJ Case Rep Año: 2021 Tipo del documento: Article País de afiliación: Suiza

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google